project id: TCGA-OV; case submitter id: TCGA-30-1869; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.2; age at index: 50; days to birth: -18398; days to death: 1563; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1954; year of death: 2008; age at diagnosis: 18398; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1563.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; preservation method: Unknown; sample id: b0d7387a-b93c-4eb9-a864-04dad488b702; sample submitter id: TCGA-30-1869-01A; portion id: c9f1c87b-e2f6-4c13-b565-54b8556b55fb; portion submitter id: TCGA-30-1869-01A-01; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0;